Presence of a consensus DNA motif at nearby DNA sequence of the mutation susceptible CG nucleotides.

Complexity in tissues affected by cancer arises from somatic mutations and epigenetic modifications in the genome. The mutation susceptible hotspots present within the genome indicate a non-random nature and/or a position specific selection of mutation. An association exists between the occurrence of mutations and epigenetic DNA methylation. This study is primarily aimed at determining mutation status, and identifying a signature for predicting mutation prone zones of tumor suppressor (TS) genes. Nearby sequences from the top five positions having a higher mutation frequency in each gene of 42 TS genes were selected from a cosmic database and were considered as mutation prone zones. The conserved motifs present in the mutation prone DNA fragments were identified. Molecular docking studies were done to determine putative interactions between the identified conserved motifs and enzyme methyltransferase DNMT1. Collective analysis of 42 TS genes found GC as the most commonly replaced and AT as the most commonly formed residues after mutation. Analysis of the top 5 mutated positions of each gene (210 DNA segments for 42 TS genes) identified that CG nucleotides of the amino acid codons (e.g., Arginine) are most susceptible to mutation, and found a consensus DNA "T/AGC/GAGGA/TG" sequence present in these mutation prone DNA segments. Similar to TS genes, analysis of 54 oncogenes not only found CG nucleotides of the amino acid Arg as the most susceptible to mutation, but also identified the presence of similar consensus DNA motifs in the mutation prone DNA fragments (270 DNA segments for 54 oncogenes) of oncogenes. Docking studies depicted that, upon binding of DNMT1 methylates to this consensus DNA motif (C residues of CpG islands), mutation was likely to occur. Thus, this study proposes that DNMT1 mediated methylation in chromosomal DNA may decrease if a foreign DNA segment containing this consensus sequence along with CG nucleotides is exogenously introduced to dividing cancer cells.

[1]  Keith D Robertson,et al.  DNA methylation, methyltransferases, and cancer , 2001, Oncogene.

[2]  H. Eagle.  THE SPECIFIC AMINO ACID REQUIREMENTS OF A HUMAN CARCINOMA CELL (STRAIN HELA) IN TISSUE CULTURE , 1955, The Journal of experimental medicine.

[3]  Chris Sander,et al.  Pan-Cancer Analysis of Mutation Hotspots in Protein Domains. , 2015, Cell systems.

[4]  W. Hammond,et al.  Aspects of amino acid and protein metabolism in cancer‐bearing states , 1985, Cancer.

[5]  A. González-Angulo,et al.  A new hypothesis for the cancer mechanism , 2011, Cancer and Metastasis Reviews.

[6]  B. Fuchs,et al.  Stressing out over survival: glutamine as an apoptotic modulator. , 2006, The Journal of surgical research.

[7]  J. Valverde,et al.  RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database , 2005, BMC Genetics.

[8]  Wendy Dean,et al.  Activation-induced Cytidine Deaminase Deaminates 5-Methylcytosine in DNA and Is Expressed in Pluripotent Tissues , 2004, Journal of Biological Chemistry.

[9]  P. Ruggerone,et al.  Different molecular mechanisms of inhibition of bovine viral diarrhea virus and hepatitis C virus RNA-dependent RNA polymerases by a novel benzimidazole. , 2013, Biochemistry.

[10]  Rodrigo Lopez,et al.  Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..

[11]  Y. Nakagawa,et al.  Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer , 2016, Oncotarget.

[12]  Wen-Hsiung Li,et al.  Nonrandomness of point mutation as reflected in nucleotide substitutions in pseudogenes and its evolutionary implications , 2005, Journal of Molecular Evolution.

[13]  M. Comb,et al.  CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 , 1990, Nucleic Acids Res..

[14]  S. Saxena,et al.  A Molecular Analysis Provides Novel Insights into Androgen Receptor Signalling in Breast Cancer , 2015, PloS one.

[15]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[16]  Combining evidence for association from transmission disequilibrium and case-control studies using single-nucleotide polymorphisms , 2005, BMC Genetics.

[17]  A. Jeltsch,et al.  Biochemistry and biology of mammalian DNA methyltransferases , 2004, Cellular and Molecular Life Sciences CMLS.

[18]  Rodrigo Lopez,et al.  A new bioinformatics analysis tools framework at EMBL–EBI , 2010, Nucleic Acids Res..

[19]  J. Elser,et al.  Ecological nitrogen limitation shapes the DNA composition of plant genomes. , 2009, Molecular biology and evolution.

[20]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[21]  David N. Cooper,et al.  The CpG dinucleotide and human genetic disease , 1988, Human Genetics.

[22]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[23]  N. Socci,et al.  Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity , 2015, Nature Biotechnology.

[24]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[25]  S. Kelly,et al.  Dietary nitrogen alters codon bias and genome composition in parasitic microorganisms , 2016, Genome Biology.

[26]  Z. Ronai,et al.  Environmental factors as regulators and effectors of multistep carcinogenesis. , 1999, Carcinogenesis.

[27]  J. Medina-Franco,et al.  Advances in the computational development of DNA methyltransferase inhibitors. , 2011, Drug discovery today.

[28]  Woody Sherman,et al.  Use of an Induced Fit Receptor Structure in Virtual Screening , 2006, Chemical biology & drug design.

[29]  Peter A. Jones,et al.  Cancer genetics and epigenetics: two sides of the same coin? , 2012, Cancer cell.

[30]  J. Herman,et al.  Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours , 2002, The Journal of pathology.

[31]  M. S. Panwar,et al.  Is cholesterol a mediator of cold-induced cancer? , 2016, Tumor Biology.

[32]  S. Iguchi-Ariga,et al.  CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. , 1989, Genes & development.

[33]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[34]  Susan J Clark,et al.  DNA methylation and gene silencing in cancer: which is the guilty party? , 2002, Oncogene.

[35]  I. Tannock,et al.  Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.

[36]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[37]  M. Bissell,et al.  Breast cancer by proxy: can the microenvironment be both the cause and consequence? , 2009, Trends in molecular medicine.

[38]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[39]  M. Tang,et al.  Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair , 2006, Proceedings of the National Academy of Sciences.

[40]  V. Suzannec Klimberg,et al.  Glutamine, cancer, and its therapy* , 1996 .

[41]  W. Schaffner,et al.  Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. , 1988, Genes & development.

[42]  Yigong Shi,et al.  A proposed role for glutamine in cancer cell growth through acid resistance , 2013, Cell Research.

[43]  H. Fang,et al.  The structure and function of histone deacetylases: the target for anti-cancer therapy. , 2008, Current medicinal chemistry.

[44]  Xiaolin Zhou,et al.  Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations , 2014, Scientific Reports.

[45]  M. Robert,et al.  DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.

[46]  Robert C. Edgar,et al.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity , 2004, BMC Bioinformatics.

[47]  D. Cooper,et al.  Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-->AT transition in the K-ras oncogene. , 1997, Carcinogenesis.

[48]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[49]  R. Friesner,et al.  New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. , 2006, Bioorganic & medicinal chemistry.

[50]  J. Herman,et al.  DNA methylation, chromatin inheritance, and cancer , 2001, Oncogene.

[51]  J. Elser,et al.  Signatures of ecological resource availability in the animal and plant proteomes. , 2006, Molecular biology and evolution.

[52]  Nicholas M. Luscombe,et al.  Evidence of non-random mutation rates suggests an evolutionary risk management strategy , 2012, Nature.

[53]  Sanguthevar Rajasekaran,et al.  qPMS9: An Efficient Algorithm for Quorum Planted Motif Search , 2015, Scientific Reports.

[54]  T. Sugimura,et al.  Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. , 2000, Carcinogenesis.

[55]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[56]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[57]  Eduardo P C Rocha,et al.  Base composition bias might result from competition for metabolic resources. , 2002, Trends in genetics : TIG.

[58]  P. Ainsworth,et al.  Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). , 1997, American journal of human genetics.

[59]  M Vihinen,et al.  Sequence specificity in CpG mutation hotspots , 1996, FEBS letters.

[60]  Leslie Cope,et al.  Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis , 2008, PLoS medicine.

[61]  B. Druker,et al.  Oncogenes and Tumor Suppressors (795 articles) , 2004 .

[62]  D. Patel,et al.  Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation , 2011, Science.